My ePortfolio Register   

(2/6) ASCO 2017: LATITUDE data

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.06.17
Views: 259

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

Section 2 - LATITUDE

Dr Neal Shore (Carolina Urologic Research Center, South Carolina, USA) chairs a discussion with Prof Karim Fizazi (Department of Cancer Medicine, Institut Gustave Roussey, France), Prof Kurt Miller (Benjamin Franklin Medical Centre, Berlin, Germany) and Prof Nicholas James (Institute of Cancer and Genomic Sciences, Queen Elizabeth Hospital, Birmingham, UK).

Reflecting on the latest prostate cancer data presented at ASCO 2017, the panel covers:

-The current challenges today in prostate cancer

-Highlights from research presented at the 2017 ASCO Annual Meeting including STAMPEDE and LATITUDE

-What does the latest research mean for the immediate management of prostate cancer?

-Questions from the audience

To find out more watch section 3 here.


This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence